Hill JM - Search Results

1

Immune mobilization of autologous blood progenitor cells: direct influence on the cellular subsets collected.

Meehan KR, Talebian L, Wu J, Hill JM, Szczepiorkowski ZM, Sentman CL, Ernstoff MS. Meehan KR, et al. Among authors: hill jm. Cytotherapy. 2010 Dec;12(8):1013-21. doi: 10.3109/14653249.2010.515580. Epub 2010 Sep 27. Cytotherapy. 2010. PMID: 20873991 Free PMC article. Clinical Trial.

2

Early recovery of aggressive cytotoxic cells and improved immune resurgence with post-transplant immunotherapy for multiple myeloma.

Meehan KR, Wu J, Bengtson E, Hill J, Ely P, Szczepiorkowski Z, Kendall M, Ernstoff MS. Meehan KR, et al. Bone Marrow Transplant. 2007 Jun;39(11):695-703. doi: 10.1038/sj.bmt.1705665. Epub 2007 Apr 9. Bone Marrow Transplant. 2007. PMID: 17417660 Clinical Trial.

3

Implementation of peripheral blood CD34 analyses to initiate leukapheresis: marked reduction in resource utilization.

Meehan KR, Hill JM, Patchett L, Webber SM, Wu J, Ely P, Szczepiorkowski ZM. Meehan KR, et al. Among authors: hill jm. Transfusion. 2006 Apr;46(4):523-9. doi: 10.1111/j.1537-2995.2006.00774.x. Transfusion. 2006. PMID: 16584427

4

Novel mobilization strategies to enhance autologous immune effector cells in multiple myeloma.

Talebian L, Wu JY, Fischer DA, Hill JM, Szczepiorkowski ZM, Ernstoff MS, Sentman CL, Meehan KR. Talebian L, et al. Among authors: hill jm. Front Biosci (Elite Ed). 2011 Jun 1;3(4):1500-8. doi: 10.2741/e351. Front Biosci (Elite Ed). 2011. PMID: 21622154 Free PMC article.

5

Adoptive cellular therapy using cells enriched for NKG2D+CD3+CD8+T cells after autologous transplantation for myeloma.

Meehan KR, Talebian L, Tosteson TD, Hill JM, Szczepiorkowski Z, Sentman CL, Ernstoff MS. Meehan KR, et al. Among authors: hill jm. Biol Blood Marrow Transplant. 2013 Jan;19(1):129-37. doi: 10.1016/j.bbmt.2012.08.018. Epub 2012 Sep 10. Biol Blood Marrow Transplant. 2013. PMID: 22975165 Free PMC article. Clinical Trial.

6

Ex vivo expansion of non-MHC-restricted cytotoxic effector cells as adoptive immunotherapy for myeloma.

Wu JY, Ernstoff MS, Hill JM, Cole B, Meehan KR. Wu JY, et al. Among authors: hill jm. Cytotherapy. 2006;8(2):141-8. doi: 10.1080/14653240600620218. Cytotherapy. 2006. PMID: 16698687

7

Extracorporeal photopheresis for graft versus host disease: Identifying a clinical pathway and associated resource utilization.

Yerrabothala S, Talebian L, Klinker K, Hickman J, Hill JM, Hayes C, Lowrey C, Szczepiorkowski ZM, Meehan KR. Yerrabothala S, et al. Among authors: hill jm. J Clin Apher. 2018 Jun;33(3):310-315. doi: 10.1002/jca.21606. Epub 2017 Nov 28. J Clin Apher. 2018. PMID: 29193271

8

The financial requirements and time commitments of caregivers for autologous stem cell transplant recipients.

Meehan KR, Fitzmaurice T, Root L, Kimtis E, Patchett L, Hill J. Meehan KR, et al. J Support Oncol. 2006 Apr;4(4):187-90. J Support Oncol. 2006. PMID: 16669462

9

Syngeneic transplant in mantle cell lymphoma: a rare event and review of the literature.

Engman CA, Hill JM, Meehan KR. Engman CA, et al. Among authors: hill jm. Clin Adv Hematol Oncol. 2009 May;7(5):321-3. Clin Adv Hematol Oncol. 2009. PMID: 19521320 Review. No abstract available.

10

The practical application of chimerism analyses in allogeneic stem cell transplant recipients: blood chimerism is equivalent to marrow chimerism.

Rauwerdink CA, Tsongalis GJ, Tosteson TD, Hill JM, Meehan KR. Rauwerdink CA, et al. Among authors: hill jm. Exp Mol Pathol. 2012 Dec;93(3):339-44. doi: 10.1016/j.yexmp.2012.07.003. Epub 2012 Jul 28. Exp Mol Pathol. 2012. PMID: 22850633

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

755 results

Search Page

Filters